Promising new MRI technique provides insight into stroke October 20, 2014 -- Researchers from several institutions have used a 21-tesla preclinical MR spectroscopy scanner to develop a new technique for evaluating patients for stroke and possibly neurodegenerative diseases. They believe the protocol could be migrated to 3- and 7-tesla MRI scanners being used clinically.
CT corrects the record on arthritis in ancient Egypt October 20, 2014 -- Using CT, Egyptian researchers found that ancient Egyptian royal families appear to have suffered from a degenerative spinal disease rather than an inflammatory type of arthritis, as previously assumed. Study results were published online in Arthritis and Rheumatology.
One-time charges hit Philips Healthcare profit October 20, 2014 -- A collection of one-time charges and write-downs contributed to sharply lower earnings at Philips Healthcare in the third quarter, even as sales grew slightly after currency adjustments.
Mediso launches PET/CT research scanner October 20, 2014 -- Mediso Medical Imaging Systems has launched its new MultiScan LFER 150 PET/CT scanner, dedicated to research applications in clinical and preclinical imaging.
Payment parity in radiation therapy best serves cancer patients October 17, 2014 -- Freestanding radiation treatment centers play a vital role in ensuring access to state-of-the-art radiation therapy. But a recent article on AuntMinnie.com about reimbursement rates at these centers provided a misleading picture, according to Dr. Paul Wallner, senior vice president of 21st Century Oncology.
Elekta renews ASRT scholarship commitment October 17, 2014 -- Elekta said it has renewed its partnership with the American Society of Radiologic Technologists (ASRT) Foundation to provide training scholarships through 2019.
Rayence teams up with NHD October 17, 2014 -- Rayence has partnered with National Healthcare Distributors (NHD) to become a preferred vendor for flat-panel digital detectors.
Ground Fluor inks radiopharma license with MGH October 17, 2014 -- Ground Fluor Pharmaceuticals has signed an exclusive licensing agreement with Massachusetts General Hospital (MGH) for newly developed aryliodonium ylide chemistry.